Handok (XKRX:002390) ROCE % : -28.59% (As of Dec. 2024)

View and export this data going back to 1976. Start your Free Trial

What is Handok ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Handok's annualized ROCE % for the quarter that ended in Dec. 2024 was -28.59%.

Handok ROCE % Historical Data

The historical data trend for Handok's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handok ROCE % Chart

Handok Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

9.12

1.82

2.67

-3.62

-9.47

Handok Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-10.02	1.31	-7.90	-1.91	-28.59

Handok ROCE % Calculation

Handok's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-44356.826	/	( ( (790339.658 - 301467.892)	+	(788555.007 - 340995.943) )	/ 2 )
	=	-44356.826	/	( (488871.766	+	447559.064)	/ 2 )
	=	-44356.826	/	468215.415
	=	-9.47 %

Handok's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-134295.828	/	( ( (811316.706 - 319539.564)	+	(788555.007 - 340995.943) )	/ 2 )
	=	-134295.828	/	( ( 491777.142	+	447559.064 )	/ 2 )
	=	-134295.828	/	469668.103
	=	-28.59 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Handok (XKRX:002390) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Handok ROCE % Related Terms

Thank you for viewing the detailed overview of Handok's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Handok Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handok Inc (XKRX:002390) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

132 Teheran Street, Gangnam-gu, Seoul, KOR, 06235

Website

http://www.handok.co.kr

Handok Inc is engaged in the healthcare sector. It is one of the leading pharmaceutical companies in Korea involved in the development of prescription drugs and OTC drugs, medical devices and in-vitro diagnostics. Its products address major diseases such as diabetes, hypertension and cardiovascular diseases.

Handok Headlines

No Headlines